Urokinase biosimilar - Tasly PharmaceuticalAlternative Names: Recombinant human urokinase - Tasly Pharmaceuticals; rhPro-uk - Tasly Pharmaceuticals
Latest Information Update: 27 Apr 2016
Price : $50
At a glance
- Originator Tasly Pharmaceuticals, Inc.
- Class Plasminogen activator enzymes; Thrombolytics
- Mechanism of Action Plasminogen activators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Myocardial infarction
Most Recent Events
- 21 Nov 2011 Launched for Myocardial infarction in China (IV)